These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20866043)

  • 21. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
    Kong M; Fan J; Dong A; Cheng H; Xu R
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
    Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Li JY; Yu J; Du XS; Zhang HM; Wang B; Guo H; Bai J; Wang JH; Liu A; Wang YL
    Oncol Rep; 2016 Jul; 36(1):147-54. PubMed ID: 27177149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
    Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
    Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted inhibition of the PI3K/AKT/mTOR pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer.
    Li XQ; Cheng XJ; Wu J; Wu KF; Liu T
    Cell Mol Biol Lett; 2024 Apr; 29(1):58. PubMed ID: 38649803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH; Jang AH; Yoo CG
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):412-21. PubMed ID: 25633180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1.
    Chen J; Lan T; Hou J; Zhang J; An Y; Tie L; Pan Y; Liu J; Li X
    Int J Biochem Cell Biol; 2012 May; 44(5):759-69. PubMed ID: 22305890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
    Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q
    Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
    Silva IT; Carvalho A; Lang KL; Dudek SE; Masemann D; Durán FJ; Caro MS; Rapp UR; Wixler V; Schenkel EP; Simões CM; Ludwig S
    PLoS One; 2015; 10(2):e0117794. PubMed ID: 25674792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
    Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
    Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.
    Zhao FY; Han J; Chen XW; Wang J; Wang XD; Sun JG; Chen ZT
    Int J Mol Med; 2016 Jul; 38(1):183-91. PubMed ID: 27177336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of MicroRNA 221 and the PI3-K/Akt signaling pathways.
    Chiang EP; Chiu SC; Pai MH; Wang YC; Wang FY; Kuo YH; Tang FY
    J Agric Food Chem; 2013 May; 61(20):4839-49. PubMed ID: 23663050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.
    Pal HC; Sharma S; Strickland LR; Agarwal J; Athar M; Elmets CA; Afaq F
    PLoS One; 2013; 8(10):e77270. PubMed ID: 24124611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
    Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
    Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.